BMS is exiting the first U.S.-China pharmaceutical joint venture. Kalexo Bio and Ollin Biosciences have launched with big ...

Learn more about whether Alnylam Pharmaceuticals, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ ...

As the Houston region positions itself to become a national hub for pharmaceutical manufacturing, San Jacinto College is ...

In today’s Pharmaceutical Executive Daily, we explore how AI is disrupting higher education and career pathways, AllRock ...

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is one of the best affordable biotech stocks to invest in now . Rigel ...

Innovative Pharmaceutical Biotech ( ($HK:0399) ) just unveiled an announcement. Innovative Pharmaceutical Biotech Limited has announced a further ...

Shares of Verrica Pharmaceuticals (NASDAQ:VRCA) jumped 27% on Friday after the biotech said its partner Torii Pharmaceutical ...

Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small ...

KARACHI: Ali & Associates, in collaboration with the US Consulate General Karachi, successfully hosted a high-level ...

Cash-strapped drug developer LB Pharmaceuticals said on Monday it was aiming for a valuation of up to $321.6 million in its New York initial public offering, potentially setting up the first sizable U ...

Swiss pharmaceutical giant Roche has agreed to acquire US biotech firm 89bio, a developer of therapies for liver and cardiometabolic diseases, in a transaction valued at up to about $3. 5 billion.

Outlining the key touchpoints for embracing change and opportunity in the “messy, tough—and fun” R&D-to-commercial transition ...